nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—ESR2—asthma	0.333	1	CbGaD
Fulvestrant—EPHX2—Zileuton—asthma	0.327	0.724	CbGbCtD
Fulvestrant—CYP3A4—Fluticasone furoate—asthma	0.00992	0.022	CbGbCtD
Fulvestrant—CYP3A4—Budesonide—asthma	0.00884	0.0196	CbGbCtD
Fulvestrant—CYP3A4—Ciclesonide—asthma	0.00809	0.0179	CbGbCtD
Fulvestrant—CYP3A4—Indacaterol—asthma	0.00809	0.0179	CbGbCtD
Fulvestrant—CYP3A4—Salmeterol—asthma	0.00752	0.0166	CbGbCtD
Fulvestrant—CYP3A4—Flunisolide—asthma	0.00752	0.0166	CbGbCtD
Fulvestrant—CYP3A4—Salbutamol—asthma	0.00752	0.0166	CbGbCtD
Fulvestrant—CYP3A4—Zileuton—asthma	0.0067	0.0148	CbGbCtD
Fulvestrant—CYP3A4—Ipratropium bromide—asthma	0.0067	0.0148	CbGbCtD
Fulvestrant—CYP3A4—Fluticasone Propionate—asthma	0.00639	0.0141	CbGbCtD
Fulvestrant—CYP3A4—Zafirlukast—asthma	0.0059	0.0131	CbGbCtD
Fulvestrant—CYP3A4—Tiotropium—asthma	0.00508	0.0112	CbGbCtD
Fulvestrant—CYP3A4—Aminophylline—asthma	0.00485	0.0107	CbGbCtD
Fulvestrant—CYP3A4—Theophylline—asthma	0.00456	0.0101	CbGbCtD
Fulvestrant—CYP3A4—Montelukast—asthma	0.00432	0.00956	CbGbCtD
Fulvestrant—CYP3A4—Loratadine—asthma	0.00432	0.00956	CbGbCtD
Fulvestrant—CYP3A4—Methylprednisolone—asthma	0.00395	0.00874	CbGbCtD
Fulvestrant—CYP3A4—Triamcinolone—asthma	0.00299	0.00663	CbGbCtD
Fulvestrant—CYP3A4—Betamethasone—asthma	0.00257	0.00568	CbGbCtD
Fulvestrant—CYP3A4—Prednisolone—asthma	0.00253	0.00561	CbGbCtD
Fulvestrant—CYP3A4—Hydrocortisone—asthma	0.0024	0.00532	CbGbCtD
Fulvestrant—CYP3A4—Prednisone—asthma	0.00239	0.0053	CbGbCtD
Fulvestrant—NR1H4—adrenal cortex—asthma	0.00217	0.0729	CbGeAlD
Fulvestrant—NR1H4—cardiovascular system—asthma	0.00198	0.0665	CbGeAlD
Fulvestrant—ESRRA—respiratory system—asthma	0.00198	0.0665	CbGeAlD
Fulvestrant—EPHX2—adrenal cortex—asthma	0.0019	0.0637	CbGeAlD
Fulvestrant—ESRRA—adrenal cortex—asthma	0.00166	0.0558	CbGeAlD
Fulvestrant—ESRRA—bronchus—asthma	0.00163	0.0547	CbGeAlD
Fulvestrant—NR1H4—adrenal gland—asthma	0.00157	0.0526	CbGeAlD
Fulvestrant—ESRRA—cardiovascular system—asthma	0.00152	0.0509	CbGeAlD
Fulvestrant—CYP3A4—Dexamethasone—asthma	0.00149	0.00331	CbGbCtD
Fulvestrant—ESRRA—trachea—asthma	0.00146	0.0491	CbGeAlD
Fulvestrant—EPHX2—adrenal gland—asthma	0.00137	0.046	CbGeAlD
Fulvestrant—EPHX2—lung—asthma	0.0012	0.0403	CbGeAlD
Fulvestrant—ESRRA—adrenal gland—asthma	0.0012	0.0403	CbGeAlD
Fulvestrant—ESR2—respiratory system—asthma	0.00119	0.0399	CbGeAlD
Fulvestrant—ESRRA—lung—asthma	0.00105	0.0353	CbGeAlD
Fulvestrant—ESR2—epithelium—asthma	0.000993	0.0333	CbGeAlD
Fulvestrant—ESR2—smooth muscle tissue—asthma	0.000957	0.0321	CbGeAlD
Fulvestrant—ESR2—cardiovascular system—asthma	0.00091	0.0306	CbGeAlD
Fulvestrant—ESR1—respiratory system—asthma	0.000814	0.0273	CbGeAlD
Fulvestrant—ESR2—adrenal gland—asthma	0.00072	0.0242	CbGeAlD
Fulvestrant—ESR1—epithelium—asthma	0.00068	0.0228	CbGeAlD
Fulvestrant—ESR1—smooth muscle tissue—asthma	0.000655	0.022	CbGeAlD
Fulvestrant—ESR2—lung—asthma	0.000631	0.0212	CbGeAlD
Fulvestrant—ESR1—cardiovascular system—asthma	0.000623	0.0209	CbGeAlD
Fulvestrant—Estradiol—ESR2—asthma	0.000493	0.785	CrCbGaD
Fulvestrant—ESR1—adrenal gland—asthma	0.000493	0.0166	CbGeAlD
Fulvestrant—ESR1—lung—asthma	0.000432	0.0145	CbGeAlD
Fulvestrant—Estradiol—ALB—asthma	0.000135	0.215	CrCbGaD
Fulvestrant—Asthenia—Salbutamol—asthma	6.33e-05	0.000481	CcSEcCtD
Fulvestrant—Vomiting—Mometasone—asthma	6.33e-05	0.000481	CcSEcCtD
Fulvestrant—Hypersensitivity—Budesonide—asthma	6.29e-05	0.000478	CcSEcCtD
Fulvestrant—Immune system disorder—Hydrocortisone—asthma	6.28e-05	0.000477	CcSEcCtD
Fulvestrant—Rash—Mometasone—asthma	6.27e-05	0.000477	CcSEcCtD
Fulvestrant—Dermatitis—Mometasone—asthma	6.27e-05	0.000476	CcSEcCtD
Fulvestrant—Diarrhoea—Montelukast—asthma	6.26e-05	0.000475	CcSEcCtD
Fulvestrant—Pruritus—Salbutamol—asthma	6.24e-05	0.000474	CcSEcCtD
Fulvestrant—Headache—Mometasone—asthma	6.23e-05	0.000473	CcSEcCtD
Fulvestrant—Dizziness—Arformoterol—asthma	6.18e-05	0.000469	CcSEcCtD
Fulvestrant—Dizziness—Formoterol—asthma	6.18e-05	0.000469	CcSEcCtD
Fulvestrant—Asthenia—Budesonide—asthma	6.13e-05	0.000466	CcSEcCtD
Fulvestrant—Malnutrition—Hydrocortisone—asthma	6.05e-05	0.00046	CcSEcCtD
Fulvestrant—Dizziness—Montelukast—asthma	6.05e-05	0.000459	CcSEcCtD
Fulvestrant—Pruritus—Budesonide—asthma	6.04e-05	0.000459	CcSEcCtD
Fulvestrant—Diarrhoea—Salbutamol—asthma	6.03e-05	0.000458	CcSEcCtD
Fulvestrant—Haemoglobin—Dexamethasone—asthma	5.97e-05	0.000454	CcSEcCtD
Fulvestrant—Haemoglobin—Betamethasone—asthma	5.97e-05	0.000454	CcSEcCtD
Fulvestrant—Haemorrhage—Dexamethasone—asthma	5.94e-05	0.000451	CcSEcCtD
Fulvestrant—Haemorrhage—Betamethasone—asthma	5.94e-05	0.000451	CcSEcCtD
Fulvestrant—Vomiting—Arformoterol—asthma	5.94e-05	0.000451	CcSEcCtD
Fulvestrant—Vomiting—Formoterol—asthma	5.94e-05	0.000451	CcSEcCtD
Fulvestrant—Angiopathy—Methylprednisolone—asthma	5.93e-05	0.00045	CcSEcCtD
Fulvestrant—Nausea—Mometasone—asthma	5.91e-05	0.000449	CcSEcCtD
Fulvestrant—Immune system disorder—Methylprednisolone—asthma	5.9e-05	0.000448	CcSEcCtD
Fulvestrant—Rash—Arformoterol—asthma	5.89e-05	0.000447	CcSEcCtD
Fulvestrant—Rash—Formoterol—asthma	5.89e-05	0.000447	CcSEcCtD
Fulvestrant—Dermatitis—Formoterol—asthma	5.88e-05	0.000447	CcSEcCtD
Fulvestrant—Dermatitis—Arformoterol—asthma	5.88e-05	0.000447	CcSEcCtD
Fulvestrant—Headache—Arformoterol—asthma	5.85e-05	0.000444	CcSEcCtD
Fulvestrant—Headache—Formoterol—asthma	5.85e-05	0.000444	CcSEcCtD
Fulvestrant—Diarrhoea—Budesonide—asthma	5.84e-05	0.000444	CcSEcCtD
Fulvestrant—Dizziness—Salbutamol—asthma	5.83e-05	0.000443	CcSEcCtD
Fulvestrant—Vomiting—Montelukast—asthma	5.82e-05	0.000442	CcSEcCtD
Fulvestrant—Rash—Montelukast—asthma	5.77e-05	0.000438	CcSEcCtD
Fulvestrant—Dermatitis—Montelukast—asthma	5.76e-05	0.000438	CcSEcCtD
Fulvestrant—Depression—Prednisone—asthma	5.75e-05	0.000436	CcSEcCtD
Fulvestrant—Headache—Montelukast—asthma	5.73e-05	0.000435	CcSEcCtD
Fulvestrant—Malnutrition—Methylprednisolone—asthma	5.69e-05	0.000432	CcSEcCtD
Fulvestrant—Angioedema—Prednisolone—asthma	5.66e-05	0.00043	CcSEcCtD
Fulvestrant—Dizziness—Budesonide—asthma	5.65e-05	0.000429	CcSEcCtD
Fulvestrant—Vomiting—Salbutamol—asthma	5.61e-05	0.000426	CcSEcCtD
Fulvestrant—Vertigo—Prednisolone—asthma	5.57e-05	0.000423	CcSEcCtD
Fulvestrant—Rash—Salbutamol—asthma	5.56e-05	0.000422	CcSEcCtD
Fulvestrant—Dermatitis—Salbutamol—asthma	5.55e-05	0.000422	CcSEcCtD
Fulvestrant—Nausea—Arformoterol—asthma	5.55e-05	0.000421	CcSEcCtD
Fulvestrant—Nausea—Formoterol—asthma	5.55e-05	0.000421	CcSEcCtD
Fulvestrant—Angioedema—Hydrocortisone—asthma	5.53e-05	0.00042	CcSEcCtD
Fulvestrant—Headache—Salbutamol—asthma	5.52e-05	0.00042	CcSEcCtD
Fulvestrant—Back pain—Triamcinolone—asthma	5.51e-05	0.000419	CcSEcCtD
Fulvestrant—Vertigo—Hydrocortisone—asthma	5.44e-05	0.000413	CcSEcCtD
Fulvestrant—Nausea—Montelukast—asthma	5.43e-05	0.000413	CcSEcCtD
Fulvestrant—Vomiting—Budesonide—asthma	5.43e-05	0.000413	CcSEcCtD
Fulvestrant—Angiopathy—Betamethasone—asthma	5.39e-05	0.000409	CcSEcCtD
Fulvestrant—Angiopathy—Dexamethasone—asthma	5.39e-05	0.000409	CcSEcCtD
Fulvestrant—Rash—Budesonide—asthma	5.39e-05	0.000409	CcSEcCtD
Fulvestrant—Dermatitis—Budesonide—asthma	5.38e-05	0.000409	CcSEcCtD
Fulvestrant—Headache—Budesonide—asthma	5.35e-05	0.000406	CcSEcCtD
Fulvestrant—Nausea—Salbutamol—asthma	5.24e-05	0.000398	CcSEcCtD
Fulvestrant—Angioedema—Triamcinolone—asthma	5.21e-05	0.000396	CcSEcCtD
Fulvestrant—Haemoglobin—Prednisone—asthma	5.2e-05	0.000395	CcSEcCtD
Fulvestrant—Angioedema—Methylprednisolone—asthma	5.2e-05	0.000395	CcSEcCtD
Fulvestrant—Haemorrhage—Prednisone—asthma	5.17e-05	0.000393	CcSEcCtD
Fulvestrant—Myalgia—Hydrocortisone—asthma	5.15e-05	0.000391	CcSEcCtD
Fulvestrant—Anxiety—Hydrocortisone—asthma	5.14e-05	0.00039	CcSEcCtD
Fulvestrant—Vertigo—Triamcinolone—asthma	5.12e-05	0.000389	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	5.12e-05	0.000389	CcSEcCtD
Fulvestrant—Vertigo—Methylprednisolone—asthma	5.11e-05	0.000388	CcSEcCtD
Fulvestrant—Connective tissue disorder—Prednisone—asthma	5.08e-05	0.000386	CcSEcCtD
Fulvestrant—Nausea—Budesonide—asthma	5.07e-05	0.000385	CcSEcCtD
Fulvestrant—Cough—Triamcinolone—asthma	4.97e-05	0.000378	CcSEcCtD
Fulvestrant—Infection—Hydrocortisone—asthma	4.91e-05	0.000373	CcSEcCtD
Fulvestrant—Hyperhidrosis—Prednisolone—asthma	4.89e-05	0.000371	CcSEcCtD
Fulvestrant—Myalgia—Triamcinolone—asthma	4.85e-05	0.000369	CcSEcCtD
Fulvestrant—Nervous system disorder—Hydrocortisone—asthma	4.84e-05	0.000368	CcSEcCtD
Fulvestrant—Myalgia—Methylprednisolone—asthma	4.84e-05	0.000368	CcSEcCtD
Fulvestrant—Arthralgia—Methylprednisolone—asthma	4.84e-05	0.000368	CcSEcCtD
Fulvestrant—Anxiety—Methylprednisolone—asthma	4.82e-05	0.000366	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	4.81e-05	0.000365	CcSEcCtD
Fulvestrant—Skin disorder—Hydrocortisone—asthma	4.8e-05	0.000364	CcSEcCtD
Fulvestrant—Hyperhidrosis—Hydrocortisone—asthma	4.78e-05	0.000363	CcSEcCtD
Fulvestrant—Angioedema—Betamethasone—asthma	4.72e-05	0.000359	CcSEcCtD
Fulvestrant—Angioedema—Dexamethasone—asthma	4.72e-05	0.000359	CcSEcCtD
Fulvestrant—Anorexia—Hydrocortisone—asthma	4.71e-05	0.000358	CcSEcCtD
Fulvestrant—Angiopathy—Prednisone—asthma	4.69e-05	0.000357	CcSEcCtD
Fulvestrant—Immune system disorder—Prednisone—asthma	4.67e-05	0.000355	CcSEcCtD
Fulvestrant—Vertigo—Betamethasone—asthma	4.65e-05	0.000353	CcSEcCtD
Fulvestrant—Vertigo—Dexamethasone—asthma	4.65e-05	0.000353	CcSEcCtD
Fulvestrant—Infection—Triamcinolone—asthma	4.62e-05	0.000351	CcSEcCtD
Fulvestrant—Infection—Methylprednisolone—asthma	4.61e-05	0.00035	CcSEcCtD
Fulvestrant—Insomnia—Prednisolone—asthma	4.57e-05	0.000347	CcSEcCtD
Fulvestrant—Nervous system disorder—Methylprednisolone—asthma	4.55e-05	0.000346	CcSEcCtD
Fulvestrant—Paraesthesia—Prednisolone—asthma	4.54e-05	0.000345	CcSEcCtD
Fulvestrant—Skin disorder—Methylprednisolone—asthma	4.51e-05	0.000342	CcSEcCtD
Fulvestrant—Malnutrition—Prednisone—asthma	4.5e-05	0.000342	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Hydrocortisone—asthma	4.5e-05	0.000342	CcSEcCtD
Fulvestrant—Hyperhidrosis—Triamcinolone—asthma	4.5e-05	0.000342	CcSEcCtD
Fulvestrant—Hyperhidrosis—Methylprednisolone—asthma	4.49e-05	0.000341	CcSEcCtD
Fulvestrant—Insomnia—Hydrocortisone—asthma	4.47e-05	0.000339	CcSEcCtD
Fulvestrant—Paraesthesia—Hydrocortisone—asthma	4.44e-05	0.000337	CcSEcCtD
Fulvestrant—Myalgia—Dexamethasone—asthma	4.4e-05	0.000334	CcSEcCtD
Fulvestrant—Myalgia—Betamethasone—asthma	4.4e-05	0.000334	CcSEcCtD
Fulvestrant—Anxiety—Dexamethasone—asthma	4.39e-05	0.000333	CcSEcCtD
Fulvestrant—Anxiety—Betamethasone—asthma	4.39e-05	0.000333	CcSEcCtD
Fulvestrant—Dyspepsia—Hydrocortisone—asthma	4.35e-05	0.00033	CcSEcCtD
Fulvestrant—Pain—Prednisolone—asthma	4.33e-05	0.000329	CcSEcCtD
Fulvestrant—Decreased appetite—Hydrocortisone—asthma	4.29e-05	0.000326	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—asthma	4.29e-05	0.0008	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—HMOX1—asthma	4.26e-05	0.000797	CbGpPWpGaD
Fulvestrant—Gastrointestinal disorder—Hydrocortisone—asthma	4.26e-05	0.000324	CcSEcCtD
Fulvestrant—Fatigue—Hydrocortisone—asthma	4.26e-05	0.000323	CcSEcCtD
Fulvestrant—ESRRA—Gene Expression—ESR2—asthma	4.24e-05	0.000792	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Triamcinolone—asthma	4.24e-05	0.000322	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Methylprednisolone—asthma	4.23e-05	0.000321	CcSEcCtD
Fulvestrant—Pain—Hydrocortisone—asthma	4.22e-05	0.000321	CcSEcCtD
Fulvestrant—Insomnia—Triamcinolone—asthma	4.21e-05	0.00032	CcSEcCtD
Fulvestrant—ESRRA—Metabolism—ALDH2—asthma	4.2e-05	0.000785	CbGpPWpGaD
Fulvestrant—Insomnia—Methylprednisolone—asthma	4.2e-05	0.000319	CcSEcCtD
Fulvestrant—Infection—Dexamethasone—asthma	4.19e-05	0.000318	CcSEcCtD
Fulvestrant—Infection—Betamethasone—asthma	4.19e-05	0.000318	CcSEcCtD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	4.18e-05	0.000781	CbGpPWpGaD
Fulvestrant—Paraesthesia—Triamcinolone—asthma	4.18e-05	0.000317	CcSEcCtD
Fulvestrant—ESR2—Generic Transcription Pathway—SMAD3—asthma	4.17e-05	0.000778	CbGpPWpGaD
Fulvestrant—Paraesthesia—Methylprednisolone—asthma	4.17e-05	0.000317	CcSEcCtD
Fulvestrant—Anaemia—Prednisone—asthma	4.16e-05	0.000316	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—NQO1—asthma	4.16e-05	0.000776	CbGpPWpGaD
Fulvestrant—Dyspnoea—Triamcinolone—asthma	4.15e-05	0.000315	CcSEcCtD
Fulvestrant—Nervous system disorder—Dexamethasone—asthma	4.14e-05	0.000314	CcSEcCtD
Fulvestrant—Nervous system disorder—Betamethasone—asthma	4.14e-05	0.000314	CcSEcCtD
Fulvestrant—NR1H4—Gene Expression—CARM1—asthma	4.12e-05	0.00077	CbGpPWpGaD
Fulvestrant—Angioedema—Prednisone—asthma	4.11e-05	0.000313	CcSEcCtD
Fulvestrant—Dyspepsia—Triamcinolone—asthma	4.09e-05	0.000311	CcSEcCtD
Fulvestrant—ESR1—Regulation of Telomerase—TGFB1—asthma	4.09e-05	0.000764	CbGpPWpGaD
Fulvestrant—Dyspepsia—Methylprednisolone—asthma	4.09e-05	0.00031	CcSEcCtD
Fulvestrant—ESR1—Leptin signaling pathway—STAT3—asthma	4.08e-05	0.000762	CbGpPWpGaD
Fulvestrant—Hyperhidrosis—Dexamethasone—asthma	4.08e-05	0.00031	CcSEcCtD
Fulvestrant—Hyperhidrosis—Betamethasone—asthma	4.08e-05	0.00031	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—ADCY2—asthma	4.07e-05	0.00076	CbGpPWpGaD
Fulvestrant—Vertigo—Prednisone—asthma	4.05e-05	0.000307	CcSEcCtD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—POMC—asthma	4.04e-05	0.000755	CbGpPWpGaD
Fulvestrant—Gastrointestinal pain—Hydrocortisone—asthma	4.04e-05	0.000307	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PTGS2—asthma	4.03e-05	0.000753	CbGpPWpGaD
Fulvestrant—Anorexia—Betamethasone—asthma	4.02e-05	0.000306	CcSEcCtD
Fulvestrant—Anorexia—Dexamethasone—asthma	4.02e-05	0.000306	CcSEcCtD
Fulvestrant—Urticaria—Prednisolone—asthma	4.02e-05	0.000305	CcSEcCtD
Fulvestrant—ESR1—Regulation of Telomerase—EGFR—asthma	4.01e-05	0.000749	CbGpPWpGaD
Fulvestrant—Fatigue—Triamcinolone—asthma	4.01e-05	0.000305	CcSEcCtD
Fulvestrant—ESR2—Generic Transcription Pathway—NR3C1—asthma	4.01e-05	0.000748	CbGpPWpGaD
Fulvestrant—Fatigue—Methylprednisolone—asthma	4e-05	0.000304	CcSEcCtD
Fulvestrant—ESR1—AP-1 transcription factor network—TGFB1—asthma	4e-05	0.000747	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTT1—asthma	4e-05	0.000747	CbGpPWpGaD
Fulvestrant—Pain—Triamcinolone—asthma	3.98e-05	0.000302	CcSEcCtD
Fulvestrant—NR1H4—Metabolism—ALOX5AP—asthma	3.95e-05	0.000738	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALOX15—asthma	3.95e-05	0.000738	CbGpPWpGaD
Fulvestrant—Urticaria—Hydrocortisone—asthma	3.92e-05	0.000298	CcSEcCtD
Fulvestrant—Body temperature increased—Hydrocortisone—asthma	3.9e-05	0.000297	CcSEcCtD
Fulvestrant—Abdominal pain—Hydrocortisone—asthma	3.9e-05	0.000297	CcSEcCtD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—TNF—asthma	3.9e-05	0.000728	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	3.87e-05	0.000723	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Dexamethasone—asthma	3.84e-05	0.000292	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Betamethasone—asthma	3.84e-05	0.000292	CcSEcCtD
Fulvestrant—Myalgia—Prednisone—asthma	3.83e-05	0.000291	CcSEcCtD
Fulvestrant—Arthralgia—Prednisone—asthma	3.83e-05	0.000291	CcSEcCtD
Fulvestrant—Anxiety—Prednisone—asthma	3.82e-05	0.00029	CcSEcCtD
Fulvestrant—Insomnia—Betamethasone—asthma	3.82e-05	0.00029	CcSEcCtD
Fulvestrant—Insomnia—Dexamethasone—asthma	3.82e-05	0.00029	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.81e-05	0.000289	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Methylprednisolone—asthma	3.79e-05	0.000288	CcSEcCtD
Fulvestrant—Paraesthesia—Dexamethasone—asthma	3.79e-05	0.000288	CcSEcCtD
Fulvestrant—Paraesthesia—Betamethasone—asthma	3.79e-05	0.000288	CcSEcCtD
Fulvestrant—NR1H4—Metabolism—CHAT—asthma	3.77e-05	0.000704	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—CARM1—asthma	3.76e-05	0.000702	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Prednisolone—asthma	3.73e-05	0.000283	CcSEcCtD
Fulvestrant—Dyspepsia—Betamethasone—asthma	3.71e-05	0.000282	CcSEcCtD
Fulvestrant—Dyspepsia—Dexamethasone—asthma	3.71e-05	0.000282	CcSEcCtD
Fulvestrant—ESR1—Gene Expression—PRMT5—asthma	3.71e-05	0.000692	CbGpPWpGaD
Fulvestrant—Urticaria—Triamcinolone—asthma	3.69e-05	0.000281	CcSEcCtD
Fulvestrant—Urticaria—Methylprednisolone—asthma	3.69e-05	0.00028	CcSEcCtD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—ALB—asthma	3.69e-05	0.000688	CbGpPWpGaD
Fulvestrant—Body temperature increased—Triamcinolone—asthma	3.68e-05	0.000279	CcSEcCtD
Fulvestrant—Abdominal pain—Methylprednisolone—asthma	3.67e-05	0.000279	CcSEcCtD
Fulvestrant—Decreased appetite—Betamethasone—asthma	3.67e-05	0.000279	CcSEcCtD
Fulvestrant—Decreased appetite—Dexamethasone—asthma	3.67e-05	0.000279	CcSEcCtD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CDK2—asthma	3.67e-05	0.000685	CbGpPWpGaD
Fulvestrant—Infection—Prednisone—asthma	3.65e-05	0.000277	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Betamethasone—asthma	3.64e-05	0.000277	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Dexamethasone—asthma	3.64e-05	0.000277	CcSEcCtD
Fulvestrant—Hypersensitivity—Hydrocortisone—asthma	3.64e-05	0.000276	CcSEcCtD
Fulvestrant—Fatigue—Betamethasone—asthma	3.64e-05	0.000276	CcSEcCtD
Fulvestrant—Fatigue—Dexamethasone—asthma	3.64e-05	0.000276	CcSEcCtD
Fulvestrant—ESR1—Signaling by ERBB4—IL6R—asthma	3.64e-05	0.000679	CbGpPWpGaD
Fulvestrant—Pain—Dexamethasone—asthma	3.61e-05	0.000274	CcSEcCtD
Fulvestrant—Pain—Betamethasone—asthma	3.61e-05	0.000274	CcSEcCtD
Fulvestrant—Nervous system disorder—Prednisone—asthma	3.6e-05	0.000274	CcSEcCtD
Fulvestrant—ESR2—Gene Expression—CARM1—asthma	3.59e-05	0.00067	CbGpPWpGaD
Fulvestrant—Skin disorder—Prednisone—asthma	3.57e-05	0.000271	CcSEcCtD
Fulvestrant—Hyperhidrosis—Prednisone—asthma	3.55e-05	0.00027	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	3.55e-05	0.000664	CbGpPWpGaD
Fulvestrant—Asthenia—Hydrocortisone—asthma	3.54e-05	0.000269	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PTEN—asthma	3.52e-05	0.000657	CbGpPWpGaD
Fulvestrant—Anorexia—Prednisone—asthma	3.5e-05	0.000266	CcSEcCtD
Fulvestrant—Pruritus—Hydrocortisone—asthma	3.49e-05	0.000265	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—asthma	3.48e-05	0.000651	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GSTP1—asthma	3.47e-05	0.000648	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—IL6—asthma	3.45e-05	0.000645	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—DNMT1—asthma	3.45e-05	0.000645	CbGpPWpGaD
Fulvestrant—Gastrointestinal pain—Betamethasone—asthma	3.45e-05	0.000262	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Dexamethasone—asthma	3.45e-05	0.000262	CcSEcCtD
Fulvestrant—Hypersensitivity—Triamcinolone—asthma	3.43e-05	0.00026	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—HMOX1—asthma	3.42e-05	0.000639	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Methylprednisolone—asthma	3.42e-05	0.00026	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—ITPR1—asthma	3.41e-05	0.000637	CbGpPWpGaD
Fulvestrant—Diarrhoea—Hydrocortisone—asthma	3.38e-05	0.000257	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—CAT—asthma	3.37e-05	0.00063	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—VDR—asthma	3.37e-05	0.000629	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALOX5—asthma	3.36e-05	0.000627	CbGpPWpGaD
Fulvestrant—Urticaria—Betamethasone—asthma	3.35e-05	0.000255	CcSEcCtD
Fulvestrant—Urticaria—Dexamethasone—asthma	3.35e-05	0.000255	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Prednisone—asthma	3.35e-05	0.000254	CcSEcCtD
Fulvestrant—Dizziness—Prednisolone—asthma	3.34e-05	0.000254	CcSEcCtD
Fulvestrant—Asthenia—Triamcinolone—asthma	3.34e-05	0.000253	CcSEcCtD
Fulvestrant—Body temperature increased—Betamethasone—asthma	3.34e-05	0.000253	CcSEcCtD
Fulvestrant—Abdominal pain—Dexamethasone—asthma	3.34e-05	0.000253	CcSEcCtD
Fulvestrant—Abdominal pain—Betamethasone—asthma	3.34e-05	0.000253	CcSEcCtD
Fulvestrant—Body temperature increased—Dexamethasone—asthma	3.34e-05	0.000253	CcSEcCtD
Fulvestrant—Asthenia—Methylprednisolone—asthma	3.33e-05	0.000253	CcSEcCtD
Fulvestrant—Insomnia—Prednisone—asthma	3.32e-05	0.000253	CcSEcCtD
Fulvestrant—ESRRA—Metabolism—NQO1—asthma	3.32e-05	0.000621	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TNF—asthma	3.32e-05	0.00062	CbGpPWpGaD
Fulvestrant—Paraesthesia—Prednisone—asthma	3.3e-05	0.000251	CcSEcCtD
Fulvestrant—Pruritus—Triamcinolone—asthma	3.29e-05	0.00025	CcSEcCtD
Fulvestrant—Pruritus—Methylprednisolone—asthma	3.28e-05	0.000249	CcSEcCtD
Fulvestrant—NR1H4—Gene Expression—PARP1—asthma	3.27e-05	0.000611	CbGpPWpGaD
Fulvestrant—Dizziness—Hydrocortisone—asthma	3.27e-05	0.000248	CcSEcCtD
Fulvestrant—ESRRA—Metabolism—ADCY2—asthma	3.25e-05	0.000607	CbGpPWpGaD
Fulvestrant—Dyspepsia—Prednisone—asthma	3.24e-05	0.000246	CcSEcCtD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—asthma	3.22e-05	0.000602	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—SERPINE1—asthma	3.21e-05	0.0006	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CARM1—asthma	3.2e-05	0.000599	CbGpPWpGaD
Fulvestrant—Decreased appetite—Prednisone—asthma	3.19e-05	0.000243	CcSEcCtD
Fulvestrant—Rash—Prednisolone—asthma	3.19e-05	0.000242	CcSEcCtD
Fulvestrant—Dermatitis—Prednisolone—asthma	3.19e-05	0.000242	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—PLA2G4A—asthma	3.19e-05	0.000595	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GSTM1—asthma	3.19e-05	0.000595	CbGpPWpGaD
Fulvestrant—Diarrhoea—Methylprednisolone—asthma	3.18e-05	0.000241	CcSEcCtD
Fulvestrant—Fatigue—Prednisone—asthma	3.17e-05	0.000241	CcSEcCtD
Fulvestrant—Headache—Prednisolone—asthma	3.17e-05	0.000241	CcSEcCtD
Fulvestrant—NR1H4—Metabolism—DCN—asthma	3.16e-05	0.00059	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—SMAD3—asthma	3.15e-05	0.000589	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—BCL2—asthma	3.15e-05	0.000588	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL6—asthma	3.15e-05	0.000588	CbGpPWpGaD
Fulvestrant—Constipation—Prednisone—asthma	3.14e-05	0.000239	CcSEcCtD
Fulvestrant—Vomiting—Hydrocortisone—asthma	3.14e-05	0.000239	CcSEcCtD
Fulvestrant—Rash—Hydrocortisone—asthma	3.11e-05	0.000237	CcSEcCtD
Fulvestrant—Dermatitis—Hydrocortisone—asthma	3.11e-05	0.000236	CcSEcCtD
Fulvestrant—NR1H4—Gene Expression—ESR2—asthma	3.1e-05	0.000579	CbGpPWpGaD
Fulvestrant—Headache—Hydrocortisone—asthma	3.09e-05	0.000235	CcSEcCtD
Fulvestrant—Dizziness—Triamcinolone—asthma	3.08e-05	0.000234	CcSEcCtD
Fulvestrant—NR1H4—Metabolism—ALDH2—asthma	3.07e-05	0.000574	CbGpPWpGaD
Fulvestrant—Dizziness—Methylprednisolone—asthma	3.07e-05	0.000233	CcSEcCtD
Fulvestrant—ESRRA—Gene Expression—NR3C1—asthma	3.03e-05	0.000566	CbGpPWpGaD
Fulvestrant—Asthenia—Dexamethasone—asthma	3.03e-05	0.00023	CcSEcCtD
Fulvestrant—Asthenia—Betamethasone—asthma	3.03e-05	0.00023	CcSEcCtD
Fulvestrant—ESRRA—Gene Expression—PPP2CA—asthma	3.02e-05	0.000563	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL6—asthma	3.01e-05	0.000563	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—DNMT1—asthma	3.01e-05	0.000562	CbGpPWpGaD
Fulvestrant—Gastrointestinal pain—Prednisone—asthma	3.01e-05	0.000228	CcSEcCtD
Fulvestrant—Nausea—Prednisolone—asthma	3e-05	0.000228	CcSEcCtD
Fulvestrant—ESR1—Generic Transcription Pathway—PARP1—asthma	2.99e-05	0.000558	CbGpPWpGaD
Fulvestrant—Pruritus—Betamethasone—asthma	2.99e-05	0.000227	CcSEcCtD
Fulvestrant—Pruritus—Dexamethasone—asthma	2.99e-05	0.000227	CcSEcCtD
Fulvestrant—Vomiting—Triamcinolone—asthma	2.96e-05	0.000225	CcSEcCtD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—POMC—asthma	2.95e-05	0.000552	CbGpPWpGaD
Fulvestrant—Vomiting—Methylprednisolone—asthma	2.95e-05	0.000224	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—PPP2CA—asthma	2.93e-05	0.000548	CbGpPWpGaD
Fulvestrant—Nausea—Hydrocortisone—asthma	2.93e-05	0.000223	CcSEcCtD
Fulvestrant—Rash—Triamcinolone—asthma	2.93e-05	0.000223	CcSEcCtD
Fulvestrant—Dermatitis—Triamcinolone—asthma	2.93e-05	0.000223	CcSEcCtD
Fulvestrant—Rash—Methylprednisolone—asthma	2.93e-05	0.000222	CcSEcCtD
Fulvestrant—Dermatitis—Methylprednisolone—asthma	2.92e-05	0.000222	CcSEcCtD
Fulvestrant—NR1H4—Metabolism—GSTT1—asthma	2.92e-05	0.000546	CbGpPWpGaD
Fulvestrant—Urticaria—Prednisone—asthma	2.92e-05	0.000222	CcSEcCtD
Fulvestrant—Headache—Triamcinolone—asthma	2.91e-05	0.000221	CcSEcCtD
Fulvestrant—Headache—Methylprednisolone—asthma	2.91e-05	0.000221	CcSEcCtD
Fulvestrant—Abdominal pain—Prednisone—asthma	2.91e-05	0.000221	CcSEcCtD
Fulvestrant—Body temperature increased—Prednisone—asthma	2.91e-05	0.000221	CcSEcCtD
Fulvestrant—Diarrhoea—Dexamethasone—asthma	2.89e-05	0.000219	CcSEcCtD
Fulvestrant—Diarrhoea—Betamethasone—asthma	2.89e-05	0.000219	CcSEcCtD
Fulvestrant—ESR2—Gene Expression—PARP1—asthma	2.85e-05	0.000532	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—ESR2—asthma	2.83e-05	0.000528	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PTEN—asthma	2.81e-05	0.000525	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—SERPINE1—asthma	2.8e-05	0.000522	CbGpPWpGaD
Fulvestrant—Dizziness—Dexamethasone—asthma	2.79e-05	0.000212	CcSEcCtD
Fulvestrant—Dizziness—Betamethasone—asthma	2.79e-05	0.000212	CcSEcCtD
Fulvestrant—ESRRA—Metabolism—GSTP1—asthma	2.77e-05	0.000518	CbGpPWpGaD
Fulvestrant—Nausea—Triamcinolone—asthma	2.76e-05	0.00021	CcSEcCtD
Fulvestrant—Nausea—Methylprednisolone—asthma	2.76e-05	0.000209	CcSEcCtD
Fulvestrant—ESRRA—Metabolism—HMOX1—asthma	2.73e-05	0.000511	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ITPR1—asthma	2.73e-05	0.000509	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Prednisone—asthma	2.71e-05	0.000206	CcSEcCtD
Fulvestrant—ESRRA—Metabolism—CAT—asthma	2.7e-05	0.000504	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—ALB—asthma	2.69e-05	0.000503	CbGpPWpGaD
Fulvestrant—Vomiting—Dexamethasone—asthma	2.68e-05	0.000204	CcSEcCtD
Fulvestrant—Vomiting—Betamethasone—asthma	2.68e-05	0.000204	CcSEcCtD
Fulvestrant—Rash—Betamethasone—asthma	2.66e-05	0.000202	CcSEcCtD
Fulvestrant—Rash—Dexamethasone—asthma	2.66e-05	0.000202	CcSEcCtD
Fulvestrant—Dermatitis—Dexamethasone—asthma	2.66e-05	0.000202	CcSEcCtD
Fulvestrant—Dermatitis—Betamethasone—asthma	2.66e-05	0.000202	CcSEcCtD
Fulvestrant—Headache—Betamethasone—asthma	2.64e-05	0.000201	CcSEcCtD
Fulvestrant—Headache—Dexamethasone—asthma	2.64e-05	0.000201	CcSEcCtD
Fulvestrant—Asthenia—Prednisone—asthma	2.64e-05	0.0002	CcSEcCtD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—asthma	2.61e-05	0.000487	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—PTEN—asthma	2.61e-05	0.000487	CbGpPWpGaD
Fulvestrant—Pruritus—Prednisone—asthma	2.6e-05	0.000198	CcSEcCtD
Fulvestrant—ESR1—Signaling by ERBB4—PTEN—asthma	2.59e-05	0.000484	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—ALDH2—asthma	2.57e-05	0.00048	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—ALB—asthma	2.56e-05	0.000478	CbGpPWpGaD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	2.56e-05	0.000478	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PLA2G4A—asthma	2.55e-05	0.000476	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTM1—asthma	2.55e-05	0.000476	CbGpPWpGaD
Fulvestrant—Diarrhoea—Prednisone—asthma	2.51e-05	0.000191	CcSEcCtD
Fulvestrant—Nausea—Betamethasone—asthma	2.51e-05	0.00019	CcSEcCtD
Fulvestrant—Nausea—Dexamethasone—asthma	2.51e-05	0.00019	CcSEcCtD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	2.48e-05	0.000463	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—VDR—asthma	2.46e-05	0.00046	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTT1—asthma	2.45e-05	0.000457	CbGpPWpGaD
Fulvestrant—Dizziness—Prednisone—asthma	2.43e-05	0.000185	CcSEcCtD
Fulvestrant—NR1H4—Metabolism—NQO1—asthma	2.43e-05	0.000454	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ADCY2—asthma	2.38e-05	0.000444	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.36e-05	0.00044	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—VEGFA—asthma	2.36e-05	0.00044	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PPP2CA—asthma	2.35e-05	0.000438	CbGpPWpGaD
Fulvestrant—Vomiting—Prednisone—asthma	2.34e-05	0.000178	CcSEcCtD
Fulvestrant—Rash—Prednisone—asthma	2.32e-05	0.000176	CcSEcCtD
Fulvestrant—Dermatitis—Prednisone—asthma	2.32e-05	0.000176	CcSEcCtD
Fulvestrant—ESR1—Signaling Pathways—C3AR1—asthma	2.31e-05	0.000431	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FCER2—asthma	2.31e-05	0.000431	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SMAD3—asthma	2.3e-05	0.00043	CbGpPWpGaD
Fulvestrant—Headache—Prednisone—asthma	2.3e-05	0.000175	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—POMC—asthma	2.25e-05	0.000421	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—VDR—asthma	2.24e-05	0.000419	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CYSLTR2—asthma	2.22e-05	0.000415	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NR3C1—asthma	2.21e-05	0.000414	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PPP2CA—asthma	2.2e-05	0.000412	CbGpPWpGaD
Fulvestrant—Nausea—Prednisone—asthma	2.18e-05	0.000166	CcSEcCtD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—asthma	2.16e-05	0.000404	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LTB4R—asthma	2.15e-05	0.000401	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTGDR—asthma	2.15e-05	0.000401	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL22—asthma	2.15e-05	0.000401	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—VDR—asthma	2.14e-05	0.0004	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—EGFR—asthma	2.12e-05	0.000396	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—SERPINE1—asthma	2.11e-05	0.000395	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—EGFR—asthma	2.11e-05	0.000394	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—SMAD3—asthma	2.1e-05	0.000393	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	2.07e-05	0.000387	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTEN—asthma	2.05e-05	0.000384	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ALB—asthma	2.05e-05	0.000383	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTP1—asthma	2.03e-05	0.000378	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NR3C1—asthma	2.02e-05	0.000377	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SMAD3—asthma	2.01e-05	0.000375	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—HMOX1—asthma	2e-05	0.000373	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ITPR1—asthma	1.99e-05	0.000372	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CAT—asthma	1.97e-05	0.000368	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—NOS3—asthma	1.96e-05	0.000367	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	1.95e-05	0.000365	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NR3C1—asthma	1.93e-05	0.00036	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPP2CA—asthma	1.92e-05	0.000359	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PLA2G4A—asthma	1.86e-05	0.000348	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTM1—asthma	1.86e-05	0.000348	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PMCH—asthma	1.83e-05	0.000341	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTGDR2—asthma	1.83e-05	0.000341	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HRH4—asthma	1.83e-05	0.000341	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NPSR1—asthma	1.83e-05	0.000341	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—CARM1—asthma	1.81e-05	0.000338	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—POMC—asthma	1.8e-05	0.000336	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTGS2—asthma	1.8e-05	0.000335	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	1.79e-05	0.000335	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CSF2RB—asthma	1.79e-05	0.000334	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—asthma	1.76e-05	0.000328	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR8—asthma	1.75e-05	0.000327	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TACR2—asthma	1.75e-05	0.000327	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL17—asthma	1.72e-05	0.000321	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPP2CA—asthma	1.71e-05	0.00032	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTP1—asthma	1.7e-05	0.000317	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—asthma	1.67e-05	0.000312	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTP1—asthma	1.67e-05	0.000312	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ALB—asthma	1.64e-05	0.000307	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IL6—asthma	1.62e-05	0.000303	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—NOS3—asthma	1.57e-05	0.000293	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTEN—asthma	1.57e-05	0.000293	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTM1—asthma	1.56e-05	0.000291	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SERPINE1—asthma	1.55e-05	0.000289	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTM1—asthma	1.54e-05	0.000287	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PDE4A—asthma	1.53e-05	0.000286	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KIF3A—asthma	1.53e-05	0.000286	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—DNMT1—asthma	1.52e-05	0.000283	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PARP1—asthma	1.44e-05	0.000269	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—asthma	1.44e-05	0.000268	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CYSLTR1—asthma	1.43e-05	0.000268	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—SERPINE1—asthma	1.41e-05	0.000263	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—C5AR1—asthma	1.38e-05	0.000258	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—UTS2—asthma	1.38e-05	0.000258	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL11—asthma	1.38e-05	0.000258	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CMA1—asthma	1.38e-05	0.000258	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VIP—asthma	1.38e-05	0.000258	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—ESR2—asthma	1.36e-05	0.000254	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SERPINE1—asthma	1.35e-05	0.000251	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR4—asthma	1.33e-05	0.000248	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—POMC—asthma	1.32e-05	0.000246	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STAT6—asthma	1.3e-05	0.000243	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL2RB—asthma	1.28e-05	0.000239	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PDE4D—asthma	1.27e-05	0.000236	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTEN—asthma	1.25e-05	0.000234	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PDE4B—asthma	1.23e-05	0.00023	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—C5—asthma	1.23e-05	0.00023	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TACR1—asthma	1.23e-05	0.00023	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALB—asthma	1.2e-05	0.000224	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NOS3—asthma	1.15e-05	0.000214	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR3—asthma	1.13e-05	0.000211	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—POMC—asthma	1.1e-05	0.000206	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NPY—asthma	1.1e-05	0.000205	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—VDR—asthma	1.08e-05	0.000202	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AGTR2—asthma	1.06e-05	0.000198	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—asthma	1.05e-05	0.000196	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LTC4S—asthma	1.04e-05	0.000194	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EDNRB—asthma	1.02e-05	0.00019	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SMAD3—asthma	1.01e-05	0.000189	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NPS—asthma	1.01e-05	0.000188	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TAC1—asthma	1.01e-05	0.000188	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCR3—asthma	9.86e-06	0.000184	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NR3C1—asthma	9.73e-06	0.000182	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPP2CA—asthma	9.68e-06	0.000181	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CYBA—asthma	9.55e-06	0.000178	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL5—asthma	9.35e-06	0.000175	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PARP1—asthma	9.35e-06	0.000175	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTEN—asthma	9.15e-06	0.000171	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—BDKRB2—asthma	9.02e-06	0.000168	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LTA4H—asthma	9e-06	0.000168	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADCY2—asthma	8.73e-06	0.000163	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL3—asthma	8.7e-06	0.000162	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KNG1—asthma	8.2e-06	0.000153	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AGTR1—asthma	8.16e-06	0.000152	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL10—asthma	7.97e-06	0.000149	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ARG1—asthma	7.87e-06	0.000147	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NTRK1—asthma	7.82e-06	0.000146	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRB2—asthma	7.74e-06	0.000145	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ITPR1—asthma	7.32e-06	0.000137	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALDH7A1—asthma	7.12e-06	0.000133	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CD86—asthma	6.97e-06	0.00013	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EDN1—asthma	6.91e-06	0.000129	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL5—asthma	6.86e-06	0.000128	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PLA2G4A—asthma	6.83e-06	0.000128	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ARG2—asthma	6.82e-06	0.000127	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SERPINE1—asthma	6.79e-06	0.000127	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CSF2—asthma	6.76e-06	0.000126	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SMAD3—asthma	6.58e-06	0.000123	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PPP2CA—asthma	6.29e-06	0.000118	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR5—asthma	6.18e-06	0.000115	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL2RA—asthma	6.09e-06	0.000114	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—C3—asthma	6.04e-06	0.000113	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PDGFB—asthma	5.88e-06	0.00011	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALOX5AP—asthma	5.65e-06	0.000106	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALOX15—asthma	5.65e-06	0.000106	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LEP—asthma	5.62e-06	0.000105	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CHAT—asthma	5.39e-06	0.000101	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FN1—asthma	5.3e-06	9.9e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—POMC—asthma	4.83e-06	9.02e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALOX5—asthma	4.81e-06	8.98e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL2—asthma	4.73e-06	8.83e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6R—asthma	4.71e-06	8.8e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CARM1—asthma	4.59e-06	8.57e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DCN—asthma	4.52e-06	8.44e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SERPINE1—asthma	4.41e-06	8.24e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALDH2—asthma	4.4e-06	8.21e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RHOA—asthma	4.26e-06	7.95e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOS3—asthma	4.21e-06	7.87e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTT1—asthma	4.18e-06	7.81e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL8—asthma	3.74e-06	6.98e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL2—asthma	3.57e-06	6.67e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NQO1—asthma	3.48e-06	6.49e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ADCY2—asthma	3.4e-06	6.35e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP9—asthma	3.38e-06	6.31e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTEN—asthma	3.36e-06	6.28e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—asthma	3.03e-06	5.67e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STAT3—asthma	3.01e-06	5.61e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTP1—asthma	2.9e-06	5.42e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMOX1—asthma	2.86e-06	5.34e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ITPR1—asthma	2.85e-06	5.33e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CAT—asthma	2.82e-06	5.27e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TGFB1—asthma	2.79e-06	5.2e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EGFR—asthma	2.73e-06	5.1e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTM1—asthma	2.66e-06	4.98e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLA2G4A—asthma	2.66e-06	4.98e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPP2CA—asthma	2.45e-06	4.58e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—asthma	2.1e-06	3.92e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—POMC—asthma	1.88e-06	3.52e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALB—asthma	1.72e-06	3.21e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NOS3—asthma	1.64e-06	3.07e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—asthma	1.5e-06	2.81e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTEN—asthma	1.31e-06	2.45e-05	CbGpPWpGaD
